Search research articles
Contact Us
Filters
Showing results (61-70 of 181) with videos related to
Page
of 19
Sort By:
Cancer Metastasis Reviews
|
May 8, 2015
Nanomedicine as an emerging platform for metastatic lung cancer therapy
Dalit Landesman-Milo, Srinivas Ramishetti, Dan Peer
Journal of Drug Targeting
|
April 1, 2016
Advances in RNAi therapeutic delivery to leukocytes using lipid nanoparticles
Srinivas Ramishetti, Dalit Landesman-Milo, Dan Peer
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
September 28, 2016
ECM-based macroporous sponges release essential factors to support the growth of hematopoietic cells
Neta Soffer-Tsur, Dan Peer, Tal Dvir
Expert Opinion on Drug Delivery
|
September 17, 2014
Overcoming multidrug resistance with nanomedicines
Assaf Ganoth, Keren Cohen Merimi, Dan Peer
Expert Opinion on Drug Delivery
|
June 14, 2016
Harnessing nanomedicine for therapeutic intervention in glioblastoma
Anna Gutkin, Zvi R Cohen, Dan Peer
Cancer Letters
|
September 1, 2014
Modulating cancer multidrug resistance by sertraline in combination with a nanomedicine
Velthe Drinberg, Rivka Bitcover, Wolf Rajchenbach, et al.
Journal of Drug Targeting
|
October 9, 2018
Targeting central nervous system pathologies with nanomedicines
Shoshy Mizrahy, Anna Gutkin, Paolo Decuzzi, et al.
Cancer Research
|
October 20, 2004
Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models
Dan Peer, Yaron Dekel, Dina Melikhov, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
January 18, 2022
Delivery strategies of RNA therapeutics to leukocytes
Dana Tarab-Ravski, Lior Stotsky-Oterin, Dan Peer
Cancer Letters
|
October 15, 2008
Treatment of resistant human colon cancer xenografts by a fluoxetine-doxorubicin combination enhances therapeutic responses comparable to an aggressive bevacizumab regimen
Mirit Argov, Rina Kashi, Dan Peer, et al.
Page
of 19
Search research articles
Search
Showing results (61-70 of 181) with videos related to
Sort By:
Page
of 19
Cancer Metastasis Reviews
|
May 8, 2015
Nanomedicine as an emerging platform for metastatic lung cancer therapy
Dalit Landesman-Milo, Srinivas Ramishetti, Dan Peer
Journal of Drug Targeting
|
April 1, 2016
Advances in RNAi therapeutic delivery to leukocytes using lipid nanoparticles
Srinivas Ramishetti, Dalit Landesman-Milo, Dan Peer
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
September 28, 2016
ECM-based macroporous sponges release essential factors to support the growth of hematopoietic cells
Neta Soffer-Tsur, Dan Peer, Tal Dvir
Expert Opinion on Drug Delivery
|
September 17, 2014
Overcoming multidrug resistance with nanomedicines
Assaf Ganoth, Keren Cohen Merimi, Dan Peer
Expert Opinion on Drug Delivery
|
June 14, 2016
Harnessing nanomedicine for therapeutic intervention in glioblastoma
Anna Gutkin, Zvi R Cohen, Dan Peer
Cancer Letters
|
September 1, 2014
Modulating cancer multidrug resistance by sertraline in combination with a nanomedicine
Velthe Drinberg, Rivka Bitcover, Wolf Rajchenbach, et al.
Journal of Drug Targeting
|
October 9, 2018
Targeting central nervous system pathologies with nanomedicines
Shoshy Mizrahy, Anna Gutkin, Paolo Decuzzi, et al.
Cancer Research
|
October 20, 2004
Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models
Dan Peer, Yaron Dekel, Dina Melikhov, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
January 18, 2022
Delivery strategies of RNA therapeutics to leukocytes
Dana Tarab-Ravski, Lior Stotsky-Oterin, Dan Peer
Cancer Letters
|
October 15, 2008
Treatment of resistant human colon cancer xenografts by a fluoxetine-doxorubicin combination enhances therapeutic responses comparable to an aggressive bevacizumab regimen
Mirit Argov, Rina Kashi, Dan Peer, et al.
Page
of 19